Market Tracker

07/31 10:01pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

29.41
Delayed Data
As of Jul 31
 +0.19 / +0.65%
Today’s Change
13.20
Today|||52-Week Range
30.39
+74.44%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close29.22
Today’s open29.52
Day’s range29.01 - 30.00
Volume1,070,045
Average volume (3 months)536,843
Market cap$965.0M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-8.44%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book7.55

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.06+1.04%
XNCRXencor Inc+0.04+0.18%
ARNAArena Pharmaceutical...+0.07+1.76%
ACHNAchillion Pharmaceut...+0.13+1.55%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts